Screener
D&A at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
FAQ
- What is Nuvation Bio's D&A?
- Nuvation Bio (NUVB) reported D&A of $536K in Q2 2026.
- How has Nuvation Bio's D&A changed year-over-year?
- Nuvation Bio's D&A increased by 50.6% year-over-year, from $356K to $536K.
- What is the long-term trend for Nuvation Bio's D&A?
- Over 4 years (2021 to 2025), Nuvation Bio's D&A has grown at a 75.3% compound annual growth rate (CAGR), from $184K to $1.74M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about Nuvation Bio's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude